Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC reduced its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 50.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 160,540 shares of the company’s stock after selling 161,264 shares during the period. TimesSquare Capital Management LLC owned about 0.10% of Astera Labs worth $21,264,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Kestra Investment Management LLC acquired a new position in Astera Labs during the 4th quarter worth $28,000. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs in the 4th quarter valued at about $36,000. Global Retirement Partners LLC boosted its holdings in shares of Astera Labs by 3,155.6% in the 4th quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after buying an additional 284 shares during the period. ORG Wealth Partners LLC acquired a new position in shares of Astera Labs in the 4th quarter valued at about $42,000. Finally, Principal Securities Inc. acquired a new position in shares of Astera Labs in the 4th quarter valued at about $55,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Trading Down 3.6 %

ALAB stock opened at $89.90 on Thursday. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39. The company has a market capitalization of $14.26 billion and a price-to-earnings ratio of -51.97. The firm’s 50-day moving average is $118.33 and its two-hundred day moving average is $84.52.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.76% and a negative net margin of 21.05%. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 11,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the sale, the director now directly owns 456,863 shares in the company, valued at $53,681,402.50. The trade was a 2.35 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Stefan A. Dyckerhoff sold 7,814 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total transaction of $837,426.38. Following the completion of the sale, the director now owns 121,803 shares in the company, valued at $13,053,627.51. The trade was a 6.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 468,180 shares of company stock worth $49,959,630.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research reports. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a report on Tuesday, January 28th. Citigroup initiated coverage on shares of Astera Labs in a report on Monday, November 18th. They issued a “buy” rating and a $120.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Craig Hallum lifted their price target on shares of Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $115.33.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.